CAMBRIDGE, Mass.--(BUSINESS WIRE)--March 29, 2006--Altus Pharmaceuticals Inc. (Nasdaq: ALTU), a biopharmaceutical company developing and commercializing oral and injectable protein therapeutics for patients with gastrointestinal and metabolic disorders, today announced that Harry H. Penner, Jr., Co-Founder, Chairman and Chief Executive of Marinus Pharmaceuticals, Inc., has been appointed to the Altus Board of Directors and will serve as a member of Altus’ Audit Committee.
